Amigluracil is a drug produced in Russia. It belongs to the group of agents that stimulate regeneration.
Country of origin - Russia.
Produced at the St. Petersburg Research Institute of Antibiotics and Enzymes.
International name - Amigluracil.
Available in dosage form - powder for preparing a solution.
Amigluracil stimulates tissue regeneration, accelerates the healing of wounds, burns, trophic ulcers, and bedsores. Has immunomodulatory, anti-inflammatory and antioxidant effects. It is used in complex therapy to accelerate the healing of wounds, burns, trophic ulcers, bedsores, as well as in immunodeficiency conditions.